News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

New Insights into Bladder Cancer Treatment Could Help Improve Immunotherapies

Green-gloved hand holding vial of BCG

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.

Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly.

Dr. Michael Glickman

Dr. Michael Glickman

Ritu Banga Healthcare Disparities Research Awards Support Innovative Science

science and innovation

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings. Endowed through a generous $5 million gift from Board of Fellows member Ritu Banga and her husband, Ajay Banga, each $50,000 award supports projects aimed at improving health outcomes for populations that have historically faced systemic barriers to care.

“It is an honor to help bring to life the Bangas' vision of a health care system where everyone can experience high-quality care,” said Dr. Lola Brown, associate dean of research and assistant professor of research education in anesthesiology at Weill Cornell Medicine. “This year’s awardees are making important contributions to improve the health of all.”

Novel Maneuver Helps Malaria Parasite Dodge the Immune System

Anopheles mosquito

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, sometimes for years. It turns out that the parasite, Plasmodium falciparum, can shut down a key set of genes, rendering itself “immunologically invisible.”

Dr. Florini

Dr. Francesca Florini

“This finding provides another piece of the puzzle as to why malaria has been so difficult to eradicate,” said Dr. Francesca Florini, research associate in microbiology and immunology at Weill Cornell Medicine who co-led the study. Malaria infects 300-500 million people yearly, resulting in nearly 600,000 deaths globally.